Replimune Group Inc

NASDAQ:REPL   4:00:00 PM EDT
9.29
-0.04 (-0.43%)
7:35:20 PM EDT: $9.20 -0.09 (-0.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)716.13M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.58 Million
Adjusted EPS-$0.83
See more estimates
10-Day MA$9.46
50-Day MA$8.99
200-Day MA$11.06
See more pivots

Replimune Group Inc Stock, NASDAQ:REPL

500 Unicorn Park Drive, Suite 303, Woburn, Massachusetts 01801
United States of America
Phone: +1.781.222.9600
Number of Employees: 331

Description

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.